Quick Answer
Verastem, Inc. reported Research And Development Expense of $114.60 million for the year ending 2025.
- Verastem, Inc. showed an increase of +40.9% in Research And Development Expense from 2024 to 2025.
- This data is from Verastem, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Verastem, Inc.'s Research And Development Expense has grown by 1,059.6%.
- Historical annual values: Fiscal year 2025: $114.60 million | Fiscal year 2024: $81.33 million | Fiscal year 2023: $61.36 million | Fiscal year 2022: $50.56 million | Fiscal year 2021: $39.35 million | Fiscal year 2020: $41.38 million | Fiscal year 2019: $45.78 million | Fiscal year 2018: $43.65 million | Fiscal year 2017: $46.42 million | Fiscal year 2016: $19.78 million | Fiscal year 2015: $40.57 million | Fiscal year 2014: $35.45 million | Fiscal year 2013: $25.93 million | Fiscal year 2012: $21.71 million | Fiscal year 2011: $9.88 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: